Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required

ustekinumab [Ustekinumab]

tematický
125
Termíny

Stelara

 

CNTO 1275
CNTO-1275
Stelara

Perzistentní odkaz   https://www.medvik.cz/link/D000069549
Definice

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

DUI
D000069549 MeSH Prohlížeč
CUI
M0490173
Historická pozn.
2016 (2005)
Veřejná pozn.
2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011

D Chemikálie a léčiva
D12.776 proteiny 2 587
D12.776.124 krevní proteiny 911
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 494
D12.776.124.486.485.114 protilátky 1 818
D12.776.124.486.485.114.224 monoklonální protilátky 4 704
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 960
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 357
D12.776.124.486.485.114.224.060.313 alemtuzumab 125
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 456
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 45
D12.776.124.486.485.114.224.060.500 certolizumab pegol 49
D12.776.124.486.485.114.224.060.750 cetuximab 186
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 158
D12.776.124.486.485.114.224.060.790 gemtuzumab 19
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 267
D12.776.124.486.485.114.224.060.813 natalizumab 158
D12.776.124.486.485.114.224.060.829 nivolumab 461
D12.776.124.486.485.114.224.060.844 omalizumab 115
D12.776.124.486.485.114.224.060.860 palivizumab 13
D12.776.124.486.485.114.224.060.864 panitumumab 62
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 63
D12.776.124.486.485.114.224.060.875 trastuzumab 278
D12.776.124.486.485.114.224.060.937 ustekinumab 125
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 494
D12.776.124.790.651.114 protilátky 1 818
D12.776.124.790.651.114.224 monoklonální protilátky 4 704
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 960
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 357
D12.776.124.790.651.114.224.060.375 alemtuzumab 125
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 456
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 45
D12.776.124.790.651.114.224.060.500 certolizumab pegol 49
D12.776.124.790.651.114.224.060.750 cetuximab 186
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 158
D12.776.124.790.651.114.224.060.790 gemtuzumab 19
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 267
D12.776.124.790.651.114.224.060.813 natalizumab 158
D12.776.124.790.651.114.224.060.829 nivolumab 461
D12.776.124.790.651.114.224.060.844 omalizumab 115
D12.776.124.790.651.114.224.060.860 palivizumab 13
D12.776.124.790.651.114.224.060.864 panitumumab 62
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 63
D12.776.124.790.651.114.224.060.875 trastuzumab 278
D12.776.124.790.651.114.224.060.937 ustekinumab 125
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 494
D12.776.377.715.548.114 protilátky 1 818
D12.776.377.715.548.114.224 monoklonální protilátky 4 704
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 960
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 357
D12.776.377.715.548.114.224.200.375 alemtuzumab 125
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 456
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 45
D12.776.377.715.548.114.224.200.500 certolizumab pegol 49
D12.776.377.715.548.114.224.200.750 cetuximab 186
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 158
D12.776.377.715.548.114.224.200.790 gemtuzumab 19
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 267
D12.776.377.715.548.114.224.200.813 natalizumab 158
D12.776.377.715.548.114.224.200.829 nivolumab 461
D12.776.377.715.548.114.224.200.844 omalizumab 115
D12.776.377.715.548.114.224.200.860 palivizumab 13
D12.776.377.715.548.114.224.200.864 panitumumab 62
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 63
D12.776.377.715.548.114.224.200.875 trastuzumab 278
D12.776.377.715.548.114.224.200.937 ustekinumab 125